This grant is for the purpose of supporting crucial research focused on understanding the complex interplay between hormone therapy and antiretroviral drugs (ARVs). The funding opportunity aims to identify and thoroughly characterize how these two distinct types of treatments interact with each other in individuals affected by HIV infection and related co-infections. The goal is to advance pharmacological knowledge, which is essential for optimizing treatment regimens, improving patient safety, and enhancing overall outcomes. This research will pave the way for more effective and personalized therapeutic strategies for people living with HIV who also require or receive hormone-based treatments, thereby significantly contributing to comprehensive patient care.
Opportunity ID: 353260
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-24-018 |
| Funding Opportunity Title: | Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 28, 2024 |
| Last Updated Date: | Mar 28, 2024 |
| Original Closing Date for Applications: | Jul 30, 2024 |
| Current Closing Date for Applications: | Jul 30, 2024 |
| Archive Date: | Sep 04, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses County governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Independent school districts Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support research to identify and characterize the interaction between hormone therapy and antiretroviral drugs (ARVs) used for treatment and prevention of HIV and co-infections. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-018.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 353260 Full Announcement-RFA-AI-24-018 -> RFA-AI-24-018-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00287307 | Jul 10, 2024 | Jul 30, 2024 | View |
Package 1
Mandatory forms
353260 RR_SF424_5_0-5.0.pdf
353260 PHS398_CoverPageSupplement_5_0-5.0.pdf
353260 RR_OtherProjectInfo_1_4-1.4.pdf
353260 PerformanceSite_4_0-4.0.pdf
353260 RR_KeyPersonExpanded_4_0-4.0.pdf
353260 PHS398_ResearchPlan_5_0-5.0.pdf
353260 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353260 RR_Budget_3_0-3.0.pdf
353260 RR_SubawardBudget30_3_0-3.0.pdf
353260 PHS398_ModularBudget_1_2-1.2.pdf
353260 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
